期刊文献+

替格瑞洛对老年急性心肌梗死患者血小板功能及临床预后的影响 被引量:28

Effect of ticagrelor on platelet reactivity and clinical outcome in elderly acute myocardial infarction patients
下载PDF
导出
摘要 目的:探索替格瑞洛联合阿司匹林对老年急性心肌梗死(AMI)患者血小板功能及临床预后的影响。方法:纳入2013年10月至2014年10月期间在我院就诊的老年(≥65岁)AMI患者200例,随机分为氯吡格雷组(n=101)和替格瑞洛组(n=99),分别给予负荷量阿司匹林300 mg+氯吡格雷600 mg或阿司匹林300 mg+替格瑞洛180 mg,次日起改为维持剂量阿司匹林100 mg/d和氯吡格雷75 mg/d或替格瑞洛180 mg/d,用药前及用药后1、6和12个月分别检测血小板反应指数(PRI),观察主要不良心血管事件(MACE)和心肌梗死溶栓治疗(TIMI)出血事件。结果:共有196例患者完成随访,两组治疗前PRI无统计学差异;PCI术后6个月和12个月时两组PRI均较治疗前分别下降(P<0.05);与氯吡格雷组比较,替格瑞洛组在6个月和12个月时PRI降低更加明显(P<0.01);随访1年时,替格瑞洛组MACE发生率明显低于氯吡格雷组(9.2%对12.9%,P=0.01);两组TIMI出血事件发生率无差别(氯吡格雷组9.6%对替格瑞洛组10.3%,P>0.05)。结论:与氯吡格雷相比,老年AMI患者服用替格瑞洛可进一步降低MACE事件,而不增加出血风险。 Objective:To evaluate the effect of ticagrelor with aspirin on platelet activity and clinical outcome in elderly patients with of acute myocardial infarction(AMI). Methods:A number of 200 elderly AMI patients from October 2013 to October 2014 were involved in this study,and were divided into clopidogrel group(n=101)and ticagrelor group(n=99).A loading dose of aspirin 300 mg with clopidogrel 600 mg or ticagrelor 180 mg loading dose were prescribed respectively for the two groups.Then aspirin 100 mg/d with clopidogrel 75 mg/d or ticagrelor 180 mg/d were prescribed for maintenance dose from the next day.Platelet reaction index(PRI)was measured at the time before and 1,6,12 month after medication respectively.The major adverse cardiovascular events(MACE)and thrombolysis in myocardial infarction(TIMI)bleeding were observed. Results:196 patients finished follow-up.There was no statistical difference in PRI between two groups at baseline.PRI was decreased after medication at 6 and 12 months in both groups respectively(P〈0.05).Compared to the clopidogrel group,PRI in ticagrelor group decreased significantly at 6 and 12 months(P〈0.01).During 1-year follow-up,the occurrence rate of MACE in the ticagrelor group was lower than that in clopidogrel group(9.2% vs.12.9%,P=0.01).There was no statistical difference in TIMI bleeding between two groups(clopidogrel group 9.6% vs.ticagrelor group 10.3%,P〈0.05). Conclusion:Compared with clopidogrel,ticagrelor can further reduce the incidence of MACE without increase of TIMI bleeding.
出处 《国际心血管病杂志》 2016年第3期183-186,共4页 International Journal of Cardiovascular Disease
基金 上海市浦东新区卫生与计划生育委员会面上项目(PW2014A-16)
关键词 替格瑞洛 氯吡格雷 老年 Ticagrelor Clopidogrel Elderly
  • 相关文献

参考文献8

  • 1Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus dopidogrel versus elopidogrel coronary syndrome[J]. N Engl J Med, 2009, 361(11): 1045-1057. 被引量:1
  • 2Thygesen K, Alpert .IS, White HD, et al. Joint ESC/ACCF/ AHA/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction[J]. Fur Heart J, 2007, 28(20): 2525-2538. 被引量:1
  • 3Mauri L, Hsieh WH, Massaro JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents[J]. N Engl J Med, 2007, 356(10) : 1020-1029. 被引量:1
  • 4Rao AK, Pratt C, Berke A, et al. Thrombolysis in Myocardial Infarction (TIM1) Trial--phase I : hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator andstreptokinase [J ]. J Am Coil Cardiol, 1988, 11(1): 1-11. 被引量:1
  • 5O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/ AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J]. J Am Coll Cardiol, 2013, 61(4): e78- e140. 被引量:1
  • 6Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST- Segment Elevation of the European Society of Cardiology(ESC) [J]. Fur Heart J, 2016, 37(3): 267-315. 被引量:1
  • 7沈卫峰,张奇,张瑞岩.2015年急性ST段抬高型心肌梗死诊断和治疗指南解析[J].国际心血管病杂志,2015,42(4):217-219. 被引量:254
  • 8骆景光,韩凌,杨明,陈立伟,李晓红.替格瑞洛对高血小板反应性高危非ST段抬高型急性冠脉综合征患者血小板聚集率的影响[J].国际心血管病杂志,2015,42(2):133-134. 被引量:12

二级参考文献5

  • 1Hou X, Shi J, Sun H. Gene polymorphism of cytochrome P450 2C19 ~ 2 and clopidogrel resistance reflected by platelet function assays: a meta-analysis[J]. Eur J Clin Pharmacol, 2014,70(9) : 1041 1047. 被引量:1
  • 2Price MJ, Berger PB, Teirstein PS, et al. Standard- vs high- dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial[J]. J AMA, 20 l 1,305 ( 11 ) : 1097 1105. 被引量:1
  • 3Gurbel PA, Erlinge D, Ohman EM, et al. Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy [J]. JAMA, 2012, 308 ( 17 ) : 1785-1794. 被引量:1
  • 4James SK, Roe MT, Cannon CP, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial[J]. BMJ,2011,342:d3527. 被引量:1
  • 5无,沈卫峰,胡大一.非ST段抬高急性冠状动脉综合征诊断和治疗指南[J].中华心血管病杂志,2012,40(5):353-367. 被引量:676

共引文献264

同被引文献269

引证文献28

二级引证文献214

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部